Aude Weigel has extensive experience in the field of in-vivo drug metabolism and pharmacokinetics (DMPK). Currently serving as lab head at Idorsia Pharmaceuticals Ltd since June 2017, Aude Weigel previously held the position of Senior Scientific Associate in the same area. Prior to this, Aude Weigel worked at Actelion from October 2004 to June 2017 as a Senior Research Associate focused on pharmacokinetic studies within the DMPK group. Aude Weigel began the career path as a Trainee at Roche, where research focused on social interaction models of depression and anxiety, and gained additional experience as a Trainee at the Friedrich Miescher Institute for Biomedical Research. Aude Weigel holds a Licence in advanced life sciences from Université Louis Pasteur and a Master's degree in preclinical drug expertise from Université Henri Poincaré.